Biophore and its subsidiary, Zenara Pharma, receive the first approval for Cannabidiol in India
100% Made-in-India including the active ingredient Manufactured in US FDA and EU-approved facility in India Indicated for the treatment of neuro disorders Delhi NCR (India), May 16: Biophore India Pharmaceuticals has announced that it has received CDSCO approval for manufacturing and marketing of Cannabidiol active ingredient in India and its subsidiary, Zenara Pharma, has received the approval for the final product, Cannabidiol Oral Solution 100mg/ml, for […]
Continue Reading